Welcome to our dedicated page for Spok Holdings SEC filings (Ticker: SPOK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Spok Holdings, Inc. files SEC reports that document its healthcare communications business, Nasdaq-listed common stock, operating results, dividends and governance. Recent Form 8-K filings furnish quarterly and annual results, board dividend declarations, Regulation FD investor presentations and material corporate events related to executive roles and strategic realignment.
The company's proxy materials cover director elections, executive compensation, equity awards, shareholder voting matters and pay-versus-performance disclosure. Investor presentation exhibits and related filings describe risk areas for SPOK, including wireless network rationalization, paging-unit declines, dependence on the U.S. healthcare market, software sales cycles, competition, third-party vendors, product defects, security vulnerabilities and intellectual-property matters.
Todd J. Stein, a director of Spok Holdings, Inc. (SPOK), reported multiple sales of common stock in mid-August 2025. On 08/14/2025 and 08/15/2025 Mr. Stein (through his capacity as co-manager of Braeside Investments) reported dispositions across holdings tied to two investment vehicles: Braeside Capital, L.P. and Braeside Capital II, L.P. The filings show total reported disposals by or attributable to Mr. Stein including sales of 18,957 and 15,372 shares for Braeside Capital, and 44,213 and 18,044 shares for Braeside Capital II, at prices around $18.44–$18.50 per share. The reports list remaining beneficial ownership positions of 572,000 shares (Braeside Capital), 658,744 shares (Braeside Capital II) and a direct holding of 42,726 shares. Explanations state Braeside Investments serves as the investment manager and Mr. Stein disclaims beneficial ownership except to the extent of his pecuniary interest.
Form 144 for Spok Holdings, Inc. (SPOK) reports a proposed sale of 189,250 shares of common stock through Interactive Brokers, with an aggregate market value of $3,550,330.00. The filing states there are 20,590,924 shares outstanding and lists an approximate sale date of 08/14/2025 on NASDAQ. The shares were acquired on 03/17/2023 through open-market purchases and paid for in cash. The filer reports no securities sold in the past three months and certifies no undisclosed material adverse information is known.
Form 144 notice for Spok Holdings, Inc. (SPOK): The filing notifies a proposed sale of 158,000 shares of common stock (par value $0.0001) through Interactive Brokers LLC on NASDAQ, with an aggregate market value of $2,964,080.00 and 20,590,924 shares outstanding. The approximate sale date is 08/14/2025. The securities were acquired on 09/16/2022 by open market purchases from counterparties and paid in cash. The filer reports “Nothing to Report” for securities sold in the past three months and affirms they do not possess undisclosed material adverse information about the issuer.
Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation report beneficial ownership of 1,056,650 shares of Spok Holdings, Inc., representing 5.13% of the outstanding common stock. The filing states both reporting persons have sole voting power and sole dispositive power over those shares. The statement also notes that certain funds managed by Renaissance Technologies have the right to receive dividends or proceeds from the sale of these securities. The disclosure is presented on Schedule 13G and identifies Renaissance Technologies LLC as an investment adviser and Renaissance Technologies Holdings Corporation as a holding company.
Spok Holdings (SPOK) Form 144 filing: Affiliate Calvin Rice intends to sell up to 14,736 common shares through Charles Schwab on or about 05 Aug 2025. At the reference price in the notice, the block is valued at roughly $270,552.
The planned disposition equals about 0.07 % of Spok’s 20.59 million shares outstanding and follows a separate sale of 7,457 shares on 04 Aug 2025 that generated $139,667. The shares being sold were recently acquired via restricted-stock-unit (RSU) vestings on 03 Mar 2025 (8,774 shares) and 03 Jan 2025 (5,962 shares).
Given the small size relative to the float and the compensatory origin of the shares, the filing suggests a routine insider liquidity event with negligible balance-sheet impact, though some investors may note the consecutive insider sales.